WANBURYPharmaceuticals
Wanbury Ltd — PE Ratio & Valuation Analysis
₹221.95
+0.00%
Current P/E20.82xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E14.8x41.0% above avg
✅
34.5% Discount to Industry
WANBURY P/E 20.82x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.98 | ₹227 | 25.2x |
| 2024 | ₹16.89 | ₹291 | 17.2x |
| 2022 | ₹25.21 | ₹49 | 1.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Wanbury Ltd Valuation
Wanbury Ltd (WANBURY) currently trades at 20.82x earnings. The Pharmaceuticals sector average PE is 31.77x. WANBURY is trading at a discount to peers — may indicate relative value. Historically, WANBURY has traded at an average PE of 14.8x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
76.52%
Dividend Yield
0.00%
More on Wanbury Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.